| GlaxoSmithKline AG - Bactroban Nasal, Nasensalbe |
| 52361 | | 01 | | Bactroban Nasal | | Nasensalbe | | R01AX06 | | Mupirocin | | 28.01.1994 | | |
|
| Composition |
| mupirocinum 20 mg ut mupirocinum calcicum, vaselinum album, glyceroli mono/di/triadipas/alcanoas(C8,C10)/isostearas ad unguentum pro 1 g. |
| Packungsbestandteile |
| Nose ointment | | | | Active Agent | Dose |
|---|
| Mupirocin | 20 mg |
| | | | Inactive agents | Dose |
|---|
| Glyceroli Mono/di/triadipas/alcanoas(C8,c10)/ | | | Isostearas ad Unguentum | 1 g | | Vaselinum Album | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 028 | 3 g | PR | 27.45 | A | | Yes |
|
